decitabine
Ligand Summary
An azacitidine derivative and antineoplastic antimetabolite. It inhibits DNA methyltransferase to re-activate silent genes, limiting METASTASIS and NEOPLASM DRUG RESISTANCE. Decitabine is used in the treatment of MYELODISPLASTIC SYNDROMES, and ACUTE MYELOID LEUKEMIA.
UNII: 776B62CQ27
PubChem: 451668
ChEMBL: CHEMBL1201129
DrugCentral: 790
LyCHI: 7FVQT3S3U719
Target Activities
3 Activities
Items per page:
10
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | INHIBITOR | |||||
INHIBITOR | ||||||